Low incidence of androgen receptor gene mutations in human prostatic tumors using single strand conformation polymorphism analysis

Prostate

Volumn 28, Issue 3, 1996, Pages 162-171

  Evans, B A J ^a   Harper, M E ^a   Daniells, C E ^a   Watts, C E ^a   Matenhelia, S ^a   Green, J ^b   Griffiths, K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

Author keywords

androgen insensitivity syndrome; androgen receptor; gene mutations

Indexed keywords

ANDROGEN RECEPTOR; CYTOSINE; DNA; GLUTAMIC ACID; GLUTAMINE; GUANINE;

AMINO ACID SUBSTITUTION; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; SINGLE STRAND CONFORMATION POLYMORPHISM;

HUMANS; MALE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REPETITIVE SEQUENCES, NUCLEIC ACID; TUMOR CELLS, CULTURED;

EID: 0030006041     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199603)28:3<162::AID-PROS3>3.0.CO;2-H     Document Type: Article

References (32)

1. Schroder FH: Endocrine therapy for prostatic cancer: recent developments and current status: Br J Urol 71: 633-640, 1993.
2. McPhaul MJ, Marcelli M, Tilley WD, Griffin JE, Wilson JD: Androgen resistance caused by mutations in the androgen receptor gene. FASEB 5:2910-2915, 1991.
3. Griffin JE: Androgen resistance - the clinical and molecular spectrum. New Eng J Med 326:611-618, 1992.
4. Pinsky L, Trifiro M, Kaufman M, Beitel LK, Mhatre A, Kazemi-Esfarjani P, Sabbaghian N, Lumbroso R, Alvarado C, Vasiliou M, Gottileb B: Androgen resistance due to mutation of the androgen receptor. Clin Invest Med 15:456-472, 1992.
5. Batch JA, Williams DM, Davies HR, Brown BD, Evans BAJ, Hughes IA, Patterson MN: Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. Hum Mol Gen 1:497-503, 1992.
6. Quigley CA, Friedman KJ, Johnson A, Lafreniere RG, Silverman LM, Lubahn DB, Brown TR, Wilson EM, Willard HF, French FS: Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J Clin Endocrinol Metab 74:927-933, 1992.
7. Quigley CA, Evans BAJ, Simental JA, Marshke KB, Sar M, Lubahn DB, Davies P, Hughes IA, Wilson EM, French FS: Complete androgen insensitivity due to deletion of exon C of the androgen receptor gene highlights the functional importance of the second zinc finger of the androgen receptor in vivo. Mol Endocrinol 6:1103-1112, 1992.
8. Brown TR, Lubahn DB, Wilson EM, French FS, Migeon CJ, Corden JL: Functional characterization of naturally occurring mutant androgen receptors from subjects with complete androgen insensitivity. Mol Endocrinol 4:1759-1772, 1990.
9. Marcelli M, Tilley WD, Wilson CM, Griffin JE, Wilson JD, McPhaul MJ: Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance. Mol Endocrinol 4:1105-1116, 1990.
10. Sai T, Seino S, Chang C, Trifiro M, Pinsky L, Mhatre A, Kaufman M, Lambert B, Trapman J, Brinkmann AO, Rosenfield RL, Liao S: An exonic point mutation of the androgen receptor gene in a family with complete androgen insensitivity. Am J Hum Genet 46:1095-1100, 1990.
11. Ris-Stalpers C, Kuiper GGJM, Faber PW, Schweikert HU, van Rooij HCJ, Zegers ND, Hodgins MB, Degenhart HJ, Trapman J, Brinkmann AO: Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivity. Proc Natl Acad Sci USA 87:7866-7870, 1990.
12. Evans BAJ, Ismael RA, France T, Hughes IA: Analysis of androgen receptor gene structure in a patient with complete androgen insensitivity syndrome. J Endocrinol 129 (Suppl):65, 1991.
13. Veldscholte J, Ris-Stalpers C, Kuiper GGJM, Jenster G, Berrevoets C, Classen E, van Rooij HCJ, Trapman J, Brinkman AO: A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Comm 17:534-540, 1990.
14. Schuurmans ALG, Bolt J, Voorhorst M, Blankenstein MA, Mulder E: Unusual specificity of the androgen receptor in the human prostate tumour cell line LNCaP: high affinity for progestagenic and estrogenic steroids. Int J Cancer 42:917-922, 1988.
15. Brinkmann AO, Kuiper GGJM, Ris-Stalpers C, van Rooij HCJ, Romalo G, Trifiro M, Mulder E, Pinsky L, Schweikert HU, Trapman J: Androgen receptor abnormalities. J Steroid Biochem Mol Biol 40:349-352, 1991.
16. Newmark JR, Hardy DO, Tonb DC, Carter BS, Epstein JI, Isaacs WB, Brown TR, Barrack ER: Androgen receptor gene mutations in prostate cancer. Proc Natl Acad Sci USA 89:6319-6323, 1992.
17. Culig Z, Klocker H, Eberle J, Kaspar F, Hobisch A, Cronauer MV, Bartsch G: DNA sequence of the androgen receptor in prostatic tumour cell lines and tissue specimens assessed by means of the polymerase chain reaction. Prostate 22:11-22, 1993.
18. Culig Z, Hobisch A, Cronauer MV, Cato ACB, Hittmair A, Radmayr C, Eberle J, Bartsch G, Klocker H: Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone. Mol Endocrinol 7:1541-1550, 1993.
19. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fishbeck KH: Androgen receptor gene mutations in X-Iinked spinal and bulbar muscular atrophy. Nature 352:77-79, 1991.
20. Igarashi S, Tanno Y, Onodera O, Yamazaki M, Sato S, Ishikawa A, Miyatani N, Nagashima M, Ishikawa Y, Sahashi K: Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Neurology 42:2300-2302, 1992.
21. Amato AA, Prior TW, Barohn RJ, Snyder P, Papp A, Mendell JR: Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology 43:791-794, 1993.
22. 24-18) in the androgen receptor gene in human prostate cancer. Biochem Biophys Res Commun 198:74-80, 1994.
23. Mostofi FK, Sessterholm I, Sobin LH: "Histological typing of prostatic tumours. International Histological Classification of Tumours." No 22. Geneva: World Health Organization, 1980.
24. Orita M, Suzuki Y, Sekia T, Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879, 1989.
25. Orita M, Sekia T, Hayashi K: DNA sequence polymorphisms in Alu repeats. Genomics 8:271-278, 1990.
26. Lubahn DB, Brown TR, Simental JA, Higgs HN, Migeon CJ, Wilson EM, French FS: Sequence of the intron/ exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci USA 86:9534-9538, 1989.
27. McPhaul MJ, Marcelli M, Tilley WD, Griffin JE, Isidro-Gutierrez RF, Wilson JD: Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high dose androgen therapy. J Clin Invest 87:1413-1421, 1991.
28. McGuire WM, Chamness GC, Fuqua SAW: Abnormal estrogen receptor in clinical breast cancer. J Steroid Biochem Mol Biol 43:243-247, 1992.
29. Pfeffer U, Fecarotta E, Castagnetta L, Vidali G: Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines. Cancer Res 53:741-743, 1993.
30. Zoppi S, Marcelli M, Deslypere J-P, Griffin JE, Wilson JD, McPhaul MJ: Amino acid substitutions in the DNA binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. Mol Endocrinol 6:409-415, 1992.
31. Suzuki H, Sato N, Watabe Y, Masai M, Seino S, Shimazaki J: Androgen receptor gene mutations in human prostate cancer. J Steroid Biochem Mol Biol 46:759-765, 1993.
32. Gaddipati JP, Mcleod DG, Heidenberg HB, Sesterhenn IA, Finger MJ, Moul JW, Srivastava S: Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers. Cancer Res 54:2861-2864, 1994.